Prostate cancer incidence and survival in relation to education (United States)

Cancer Causes and Control

Volumn 15, Issue 9, 2004, Pages 939-945

  Steenland, Kyle ^a   Rodriguez, Carmen ^b   Mondul, Alison ^b   Calle, Eugenia E ^b  

^a EMORY UNIVERSITY   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

education; incidence; prostate cancer; socio economic status; survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; HIGH SCHOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL MODEL;

COHORT STUDIES; EDUCATIONAL STATUS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 10844237209     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10552-004-2231-5     Document Type: Article

References (20)

1. SEER (Surveillance, Epidemiology, and End Results), Cancer statistics review 1975-2003, NIH/NCI, Bethesda, Maryland (www.seer.cancer.gov/csr/ 1975_2000)
2. Weir H, Thun M, Hankey B, et al. (2003) Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Can Inst 95: 1276-1299.
3. Potoski E, Feuer E, Levin D (2001) Impact of screening on incidence and mortality of prostate cancer in the US. Epidemiol Rev 23: 181-186.
4. Tingen M, Weinrich S, Heydt D, Boyd M, Weinrich M (1998) Perceived benefits: a predictor of participation in prostate cancer screening. Cancer Nursing 21: 349-357.
5. Van Den Eeden S, Enger S, Caan B, et al. (2003) Predictors of having a PSA test (abstract). Am J Epidemiol 157: abstract 368.
6. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D (2001) Changing relationship between SES and prostate cancer incidence. JNCI 93: 705-709.
7. Ndubuisi S, Kofie V, Andoh J, Schwatrz E (1995) Black-white differences in the stage at presentation of prostate cancer in DC. Urology 46: 71-77.
8. Polednak A (1997) Stage at diagnosis of prostate cancer in Connecticut by poverty and race, Ethn Dis 7: 215-220.
9. Hoffman R, Gilliland F, Eley W, et al. (2001) Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 93: 388-395.
10. Tarman G, Kane C, Moul J, et al. (2000) Impact of SES and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56: 1016-1020.
11. Dayal HH, Polissar L, Dahlberg S (1985) Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 74: 1001-1006.
12. Calle E, Rodriguez C, Jacobs E, et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer 94: 500-511.
13. Bergman M, Calle E, Mervis C, et al. (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147: 556-562.
14. Calle EE, Terrell DD (1993) Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137: 235-241.
15. SAS User's Guide: Statistics (Version 6.07) (1991) NC: SAS Institute Cary.
16. Rothman K, Greenland S, (eds.) (1998) Modern Epidemiology. 2nd Edn. Philadelphia: Lippincott-Raven.
17. www.census.gov/population/socdemo/education/p20-528/tab01a.txt accessed May 25, 2004
18. Etzioni R, Penson D, Legler J, et al. (2002) Overdiagnosis due to PSA screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 94: 81-90.
19. Jordan TR, Price JH, King KA, Masyk T, Bedell AW (1999) The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 28: 297-303.
20. Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94: 334-357.